<?xml version="1.0" encoding="UTF-8"?>
<ref id="B14-ijerph-17-08751">
 <label>14.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nguyen</surname>
    <given-names>T.A.</given-names>
   </name>
   <name>
    <surname>Knight</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Roughead</surname>
    <given-names>E.E.</given-names>
   </name>
   <name>
    <surname>Brooks</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Mant</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Policy options for pharmaceutical pricing and purchasing: Issues for low- and middle-income countries</article-title>
  <source>Health Policy Plan.</source>
  <year>2015</year>
  <volume>30</volume>
  <fpage>267</fpage>
  <lpage>280</lpage>
  <pub-id pub-id-type="doi">10.1093/heapol/czt105</pub-id>
  <pub-id pub-id-type="pmid">24425694</pub-id>
 </element-citation>
</ref>
